日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Stromal fibroblastic mutant Trp53 promotes mammary tumor development via enhanced secretion of paracrine factors

基质成纤维细胞突变体Trp53通过增强旁分泌因子的分泌促进乳腺肿瘤的发生发展

Liu, Bin; Xiong, Shunbin; Williams-Villalobo, Abie; Chau, Gilda; Qi, Yuan; Chen, Hehua; Johnson, Carenza; Chachad, Dhruv; McDaniel, Joy; Su, Xiaoping; El-Naggar, Adel K; Lozano, Guillermina; Zhang, Yun

Efficacy of ATR Kinase Inhibitor Elimusertib Monotherapy or Combination in Tumors with DNA Damage Response Pathway and Other Genomic Alterations.

ATR激酶抑制剂Elimusertib单药或联合治疗对具有DNA损伤反应通路和其他基因组改变的肿瘤的疗效

Varadarajan Kaushik, Cruz Pico Christian X, Evans Kurt W, Raso Maria Gabriela, Rizvi Yasmeen Qamar, Zheng Xiaofeng, Chachad Dhruv, DiPeri Timothy P, Wang Bailiang, Scott Stephen M, Zhao Ming, Akcakanat Argun, Wengner Antje M, Yap Timothy A, Meric-Bernstam Funda

In silico analysis of DND1 and its co-expressed genes in human cancers

利用计算机模拟分析DND1及其在人类癌症中的共表达基因

Zhang, Yun; Li, Yafang; Chachad, Dhruv; Liu, Bin; Godavarthi, Jyotsna D; Williams-Villalobo, Abie; Lasisi, Latifat; Xiong, Shunbin; Matin, Angabin